• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值对术前放化疗的晚期低位直肠癌患者的预后影响

Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy.

作者信息

Nagasaki Toshiya, Akiyoshi Takashi, Fujimoto Yoshiya, Konishi Tsuyoshi, Nagayama Satoshi, Fukunaga Yosuke, Ueno Masashi

机构信息

Gastroenterological Center, Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

出版信息

Dig Surg. 2015;32(6):496-503. doi: 10.1159/000441396. Epub 2015 Nov 7.

DOI:10.1159/000441396
PMID:26544755
Abstract

BACKGROUND

The neutrophil-to-lymphocyte ratio (NLR) is considered an indicator of systemic inflammation and may predict prognosis in colorectal cancer. In this study, we examined the prognostic impact of NLR in patients with locally advanced low rectal cancer treated with neoadjuvant chemoradiotherapy (NACRT) followed by surgery.

METHODS

From 2004 to 2012, we analyzed 201 consecutive patients with locally advanced low rectal cancer below the peritoneal reflection who underwent NACRT and curative resection. Blood samples were obtained before NACRT. NLRs were dichotomized using a cut-off value of 3.0, which was chosen based on receiver operating characteristic analysis and previous studies, and we analyzed their relationship with clinical outcomes.

RESULTS

Forty-four (21.9%) patients had a high NLR. Moreover, a high NLR was significantly associated with elevated carcinoembryonic antigen levels before NACRT (p = 0.0154). Multivariate analysis showed that a high NLR was independently associated with worse overall survival (hazard ratio (HR) 3.38, p = 0.012). In contrast, a high NLR was not significantly associated with relapse-free survival (HR 1.073, p = 0.8438). The post-recurrence survival between patients with high and low NLRs was significantly different (p = 0.0370).

CONCLUSIONS

A high NLR (≥3.0) prior to NACRT was independently associated with poor prognosis in patients with locally advanced low rectal cancer treated with NACRT and radical resection.

摘要

背景

中性粒细胞与淋巴细胞比值(NLR)被认为是全身炎症的一个指标,可能预测结直肠癌的预后。在本研究中,我们探讨了NLR对接受新辅助放化疗(NACRT)后手术的局部晚期低位直肠癌患者预后的影响。

方法

2004年至2012年,我们分析了201例腹膜反折以下局部晚期低位直肠癌患者,这些患者均接受了NACRT和根治性切除术。在NACRT前采集血样。根据受试者工作特征分析和既往研究,将NLR分为两组,临界值为3.0,我们分析了其与临床结局的关系。

结果

44例(21.9%)患者NLR较高。此外,NLR较高与NACRT前癌胚抗原水平升高显著相关(p = 0.0154)。多因素分析显示,NLR较高与较差的总生存期独立相关(风险比(HR)3.38,p = 0.012)。相反,NLR较高与无复发生存期无显著相关性(HR 1.073,p = 0.8438)。NLR高、低患者的复发后生存期有显著差异(p = 0.0370)。

结论

对于接受NACRT和根治性切除术的局部晚期低位直肠癌患者,NACRT前NLR较高(≥3.0)与预后不良独立相关。

相似文献

1
Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy.中性粒细胞与淋巴细胞比值对术前放化疗的晚期低位直肠癌患者的预后影响
Dig Surg. 2015;32(6):496-503. doi: 10.1159/000441396. Epub 2015 Nov 7.
2
Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.基线中性粒细胞与淋巴细胞比值(≥2.8)作为接受新辅助放化疗的局部晚期直肠癌患者的预后因素。
Radiat Oncol. 2014 Dec 18;9:295. doi: 10.1186/s13014-014-0295-2.
3
Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer.全身炎症反应是接受术前放化疗的局部晚期直肠癌患者预后的预测指标。
Colorectal Dis. 2012 Oct;14(10):e701-7. doi: 10.1111/j.1463-1318.2012.03147.x.
4
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.中性粒细胞与淋巴细胞比值在新辅助放化疗治疗局部晚期直肠癌中的预后作用
Med Sci Monit. 2017 Jan 19;23:315-324. doi: 10.12659/msm.902752.
5
Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection.中性粒细胞与淋巴细胞比值对新辅助放化疗后手术切除的边界可切除胰腺导管腺癌的预后影响。
World J Surg. 2019 Dec;43(12):3153-3160. doi: 10.1007/s00268-019-05159-9.
6
Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy.接受术前放化疗的直肠癌患者术前中性粒细胞/淋巴细胞比值
Med Arch. 2016 Jul 27;70(4):256-260. doi: 10.5455/medarh.2016.70.256-260.
7
A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.一项基于炎症的预测因子研究,旨在预测局部晚期直肠癌患者接受新辅助放化疗的肿瘤反应。
Oncology. 2013;85(1):27-32. doi: 10.1159/000348385. Epub 2013 Jun 29.
8
[Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer].中性粒细胞与淋巴细胞比值对局部晚期结直肠癌患者预后的影响
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 May 25;20(5):550-554.
9
Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection.血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值在直肠癌根治性切除术后患者中不是预后生物标志物。
J Gastrointest Surg. 2018 Sep;22(9):1611-1618. doi: 10.1007/s11605-018-3781-2. Epub 2018 Apr 23.
10
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients.日本局部晚期直肠癌患者新辅助放化疗的疗效
World J Surg Oncol. 2016 Apr 30;14:136. doi: 10.1186/s12957-016-0898-1.

引用本文的文献

1
Inflammatory Response Markers as Predictors of Colorectal Cancer Prognosis.炎症反应标志物作为结直肠癌预后的预测指标
Ewha Med J. 2023 Dec;46(Suppl 1):e24. doi: 10.12771/emj.2023.e24. Epub 2023 Dec 31.
2
The Role of Pre-Treatment Inflammatory Biomarkers in Predicting Tumor Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.治疗前炎症生物标志物在预测直肠癌新辅助放化疗肿瘤反应中的作用
Medicina (Kaunas). 2025 May 8;61(5):865. doi: 10.3390/medicina61050865.
3
Prognostic value of nutrition and immune‑related biomarkers in patients with locally advanced rectal cancer treated with chemoradiotherapy.
营养和免疫相关生物标志物在接受放化疗的局部晚期直肠癌患者中的预后价值
Oncol Lett. 2024 Jul 22;28(4):447. doi: 10.3892/ol.2024.14580. eCollection 2024 Oct.
4
The Impact of Hematologic Parameters on Histopathologic Features of Colorectal Cancer.血液学参数对结直肠癌组织病理学特征的影响
Int J Gen Med. 2024 May 9;17:2029-2036. doi: 10.2147/IJGM.S463588. eCollection 2024.
5
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.中性粒细胞与淋巴细胞比值对接受新辅助放化疗的直肠癌患者完全病理缓解预测的预后意义。
Med Sci Monit. 2024 Mar 28;30:e943750. doi: 10.12659/MSM.943750.
6
Should we consider Systemic Inflammatory Response Index (SIRI) as a new diagnostic marker for rectal cancer?我们是否应将全身炎症反应指数(SIRI)视为直肠癌的一种新的诊断标志物?
Discov Oncol. 2024 Feb 21;15(1):44. doi: 10.1007/s12672-024-00895-4.
7
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) - A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group.局部晚期直肠癌炎症标志物的预测和预后价值(PILLAR)——意大利放射治疗与临床肿瘤学会(AIRO)胃肠研究组的多中心分析
Clin Transl Radiat Oncol. 2023 Jan 12;39:100579. doi: 10.1016/j.ctro.2023.100579. eCollection 2023 Mar.
8
Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis.血小板与淋巴细胞比值、中性粒细胞与淋巴细胞比值和淋巴细胞与单核细胞比值在直肠癌手术患者中的预后作用:系统评价和荟萃分析。
Langenbecks Arch Surg. 2023 Feb 13;408(1):85. doi: 10.1007/s00423-023-02786-8.
9
Prognostic value of sarcopenia in patients with rectal cancer: A meta-analysis.骨骼肌减少症对直肠癌患者预后的预测价值:一项荟萃分析。
PLoS One. 2022 Jun 24;17(6):e0270332. doi: 10.1371/journal.pone.0270332. eCollection 2022.
10
Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio.术前放化疗治疗直肠癌中性粒细胞与淋巴细胞比值的Meta分析:放化疗前后中性粒细胞与淋巴细胞比值的预后价值
Front Oncol. 2022 Feb 11;12:778607. doi: 10.3389/fonc.2022.778607. eCollection 2022.